Brain Blood Flow & Oxygen Linked to Alzheimer’s Risk: Early Detection Potential

The earliest stages of Alzheimer’s disease may not be marked by memory loss, but by subtle changes in how blood flows through the brain and delivers oxygen to cells, according to recent research from the Keck School of Medicine of USC. The findings, published in Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association, suggest that assessing cerebrovascular function – how well the brain’s blood vessels are working – could offer a new avenue for early detection and potentially, preventative intervention.

Vascular Health: A Potential Early Indicator

For decades, the focus in Alzheimer’s research has centered on the accumulation of amyloid plaques and tau tangles in the brain, hallmarks of the disease. However, this new study highlights the critical, and often overlooked, role of the brain’s vascular system. Researchers examined older adults, some with normal cognitive function and others with varying degrees of cognitive impairment. They discovered a link between simple, noninvasive measures of brain blood flow and oxygen levels and the established indicators of Alzheimer’s pathology – amyloid buildup and shrinkage of the hippocampus, a brain region vital for memory formation.

“Amyloid and tau are often considered the primary players in Alzheimer’s disease, but blood flow and oxygen delivery are as well critical,” explains Amaryllis A. Tsiknia, a PhD candidate at USC and lead author of the study. “Our results show that when the brain’s vascular system functions more like it does in healthy aging, we also see brain features that are linked to better cognitive health.” This suggests that the health of blood vessels may influence the disease process long before noticeable cognitive symptoms appear.

How Researchers Measured Brain Circulation

The USC team employed two readily available and painless techniques to assess cerebrovascular function. Transcranial Doppler ultrasound was used to measure the speed of blood flow through the brain’s major arteries. Simultaneously, near-infrared spectroscopy (NIRS) evaluated how effectively oxygen was reaching brain tissue near the surface of the cortex. Keck School of Medicine of USC reports that these techniques don’t involve injections, radiation, or strenuous tasks for patients.

These readings were then combined using advanced mathematical modeling to create indicators of overall cerebrovascular function. These indicators reflect the brain’s ability to adjust blood flow and oxygen delivery in response to natural fluctuations in blood pressure and carbon dioxide levels. Essentially, the researchers were looking at how *responsive* the brain’s vascular system was.

Linking Vascular Health to Alzheimer’s Biomarkers

The study found that participants with vascular indicators resembling those of cognitively healthy adults tended to have lower levels of amyloid and a larger hippocampus – both factors associated with a reduced risk of Alzheimer’s. This suggests a strong correlation between healthy blood flow and structural brain health. Researchers observed that individuals diagnosed with mild cognitive impairment or dementia exhibited weaker vascular function compared to those with normal cognition, further supporting the idea that declining blood vessel health is an integral part of the Alzheimer’s disease process.

“These vascular measures are capturing something meaningful about brain health,” says Meredith N. Braskie, PhD, senior author of the study and assistant professor of neurology at the Keck School of Medicine. “They appear to align with what we see on MRI and PET scans that are commonly used to study Alzheimer’s disease, providing important information about how vascular health and standard brain measures of Alzheimer’s disease risk may be related.”

Beyond Amyloid and Tau: A Broader View of Alzheimer’s

Arthur W. Toga, PhD, director of the Stevens INI, emphasizes that these findings contribute to a growing body of evidence suggesting that Alzheimer’s is not solely a neurodegenerative disease, but also involves significant vascular contributions. USC researchers believe that understanding the interplay between blood flow, oxygen regulation, amyloid, and brain structure could unlock new opportunities for early detection and potential prevention strategies.

The Potential for Wider Screening

One of the most promising aspects of this research is the potential for more accessible and affordable screening. Compared to the cost and complexity of MRI and PET imaging, transcranial Doppler ultrasound and NIRS are relatively inexpensive and easy to administer. They don’t require injections or radiation exposure, and they place minimal demands on patients. This simplicity could craft them suitable for large-scale screening programs or for individuals who are unable to undergo more intensive brain imaging.

However, it’s crucial to note that the study represents a snapshot in time and does not prove a cause-and-effect relationship. The researchers are currently conducting long-term studies to track participants and determine whether changes in these vascular measures can predict future cognitive decline or response to treatment.

Tsiknia notes, “If we can track these signals over time, we may be able to identify people at higher risk earlier and test whether improving vascular health can slow or reduce Alzheimer’s-related brain changes.”

What Comes Next: Long-Term Tracking and Intervention Studies

The research team is focused on longitudinal studies, following participants over time to determine if changes in cerebrovascular function can predict the onset of cognitive decline. Further research will also explore potential interventions aimed at improving vascular health – such as lifestyle modifications (diet, exercise) and pharmacological approaches – to see if these interventions can mitigate Alzheimer’s risk. Stevens INI has also recently received a contract to advance women’s brain health, which may provide further insights into vascular contributions to cognitive decline.

It’s important to remember that Alzheimer’s disease is a complex condition with multiple contributing factors. While these findings offer a promising new avenue for research and potential early detection, they do not suggest a simple solution. Individuals concerned about their risk of Alzheimer’s should consult with a qualified healthcare professional for personalized advice and guidance.